S.2208 - A bill to provide for the issuance of an Alzheimer's Disease Research Semipostal Stamp.115th Congress (2017-2018)
|Sponsor:||Sen. Markey, Edward J. [D-MA] (Introduced 12/07/2017)|
|Committees:||Senate - Homeland Security and Governmental Affairs|
|Latest Action:||Senate - 12/07/2017 Read twice and referred to the Committee on Homeland Security and Governmental Affairs. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: S.2208 — 115th Congress (2017-2018)All Information (Except Text)
Introduced in Senate (12/07/2017)
This bill directs the U.S. Postal Service to issue and sell an Alzheimer's Disease Research Semipostal Stamp.
Proceeds from the sale of the stamp must be transferred to the National Institutes of Health for medical research relating to Alzheimer's disease.
The stamp must be made available to the public for six years.
Any limitation relating to whether more than one semipostal stamp may be offered for sale at the same time shall not apply to the stamp issued under this bill.